Humana AI Lawsuit Over Medicare Advantage Denials: Case Status

The Humana AI lawsuit over Medicare Advantage denials, Barrows v. Humana, is a federal class action accusing the insurer of using an algorithm called nH Predict to cut off post-acute care for Medicare Advantage members, overriding what their own doctors recommended. It was filed in December 2023 in the U.S. District Court for the Western District of Kentucky, and in August 2025 a federal judge allowed the core breach-of-contract, good-faith, unjust-enrichment, and fraud claims to move forward. The case is still in its early stages, with no class yet certified and no trial date.

What Humana Is Accused of Doing

The plaintiffs say Humana replaced individualized medical review with an algorithmic prediction built by naviHealth, a company owned by UnitedHealth Group’s Optum division since 2020.1Becker’s Payer. Humana Uses AI Algorithm From UnitedHealth to Deny Medicare Advantage Claims, Lawsuit Alleges The nH Predict tool compares a patient’s diagnosis, age, living situation, and physical function against a database of roughly six million prior patients to estimate how much post-acute care the person should need and when they should be discharged.2PMC. AI in Medicare Advantage Coverage Decisions Humana contracted with naviHealth to use it for coverage decisions in skilled nursing facilities, inpatient rehabilitation hospitals, and similar post-acute settings.3McKnight’s. Humana Must Face Class Action Suit Over Use of AI in Denying Post-Acute Care

According to the complaint, Humana set an internal target to keep patients’ facility stays within one percent of the algorithm’s predicted timeline, and employees who deviated from nH Predict’s projections were disciplined or fired regardless of whether a patient actually needed more care.4ClassAction.org. Barrows et al. v. Humana, Inc. Complaint Humana would not share nH Predict’s reports with patients, treating them as proprietary.5JAMA Health Forum. AI in Medicare Advantage Coverage Decisions The plaintiffs say that when denials were appealed, they were overturned more than 90 percent of the time, which they argue shows both that the tool was inaccurate and that no meaningful human review was happening.6Georgetown Law Litigation Tracker. Barrows v. Humana Complaint When appeals climbed to an Administrative Law Judge, the complaint alleges, Humana would often pay the claim rather than let the algorithm face scrutiny.3McKnight’s. Humana Must Face Class Action Suit Over Use of AI in Denying Post-Acute Care

The Patients Behind the Case

The original plaintiffs were JoAnne Barrows of Minnesota and Susan Hagood of North Carolina, both Humana Medicare Advantage members whose post-acute care was cut short.7Georgetown Law Litigation Tracker. Barrows et al. v. Humana, Inc. An April 2024 amended complaint added three more: Sharon Merkley of Kentucky, Lorraine Kohl of Wisconsin, and Dolly Balani of Texas.8Georgetown Law Litigation Tracker. Barrows et al. v. Humana, Inc. Docket Barrows died during the litigation, and her estate was substituted into the case.9Justia. Barrows et al v. Humana, Inc.

Their stories illustrate the pattern the lawsuit describes. Merkley, who was diagnosed with the autoimmune disease bullous pemphigoid, received seven separate denials for the same skilled nursing facility care in 30 days, each one issued after she had already appealed and won. After a later hospital stay, she got five more denials under the same cycle.9Justia. Barrows et al v. Humana, Inc. Kohl fractured her right hip and had her rehabilitation denied even though she could not lift her leg. She then fell again, fractured her left hip, and had that rehabilitation denied too before Humana eventually granted the appeal.8Georgetown Law Litigation Tracker. Barrows et al. v. Humana, Inc. Docket

The case is brought on behalf of all purchasers of Humana’s Medicare Advantage products, on the theory that the practice was uniform across the company.9Justia. Barrows et al v. Humana, Inc.

What Survived the Motion to Dismiss

On August 14, 2025, Judge Rebecca Grady Jennings issued an opinion granting Humana’s motion to dismiss in part and denying it in part. Four claims survived:9Justia. Barrows et al v. Humana, Inc.

  • Breach of contract — that Humana failed to provide the coverage and individualized reviews its Medicare Advantage contracts promised.
  • Breach of the duty of good faith and fair dealing — that Humana delegated claims review to an automated process instead of case-by-case assessment.
  • Unjust enrichment — that Humana collected premiums for services it never intended to deliver.
  • Common law fraud — that Humana concealed from members that it was using AI to decide coverage.

Four state-law claims under North Carolina insurance, unfair competition, bad faith, and deceptive practices statutes were dismissed with prejudice. The plaintiffs conceded some were preempted by federal law, and the court found the remaining one too closely tied to individual Medicare benefits determinations to proceed.9Justia. Barrows et al v. Humana, Inc.

Why the Case Was Allowed to Stay in Federal Court

Humana’s main argument for dismissal was that the plaintiffs had to work through the Medicare administrative appeals process, including Quality Improvement Organization review, before suing. Judge Jennings rejected that argument. She found that forcing patients through the appeals process would be “futile” because Humana’s denial-and-re-denial cycle was “capable of repetition while evading review,” and that requiring patients to go through it risked “irreparable harm,” since they would either go without needed care or shoulder the bills themselves.3McKnight’s. Humana Must Face Class Action Suit Over Use of AI in Denying Post-Acute Care

The judge framed the surviving case narrowly. It is not about whether Humana violated the Medicare Act, she wrote, but about whether the company “knowingly violated its contract with its beneficiaries and kept the proceeds” by failing to deliver the individualized medical assessments it had promised.3McKnight’s. Humana Must Face Class Action Suit Over Use of AI in Denying Post-Acute Care

Humana’s Response

A Humana spokesperson told CBS News the company uses “various tools, including augmented intelligence,” but said a “human in the loop” is always involved and that “adverse coverage decisions are only made by physician medical directors” using CMS criteria and medical judgment.10CBS News. Health Insurance Humana United Health AI Algorithm Optum, which owns naviHealth, said nH Predict is “not used to make coverage determinations” but serves as a “guide to help us inform providers, families and other caregivers.”1Becker’s Payer. Humana Uses AI Algorithm From UnitedHealth to Deny Medicare Advantage Claims, Lawsuit Alleges

Where the Case Stands Now

As of mid-2026, the case is still early. The class has not been certified and no trial date has been set. The parties are filing joint status reports and scheduling orders, with a scheduling order issued on May 21, 2026, and the next status report due to the court by July 10, 2026.7Georgetown Law Litigation Tracker. Barrows et al. v. Humana, Inc. Lead counsel for the plaintiffs is the Guilfoyle Law Office, with the Clarkson Law Firm also representing the proposed class.11Clarkson Law Firm. Clarkson Sues Humana Over AI Denying Claims

Parallel Cases and the Bigger Picture

The Humana suit is one of three federal cases challenging AI-driven claims denials. A parallel action, Estate of Gene B. Lokken v. UnitedHealth Group, targets the same nH Predict tool in Minnesota. A federal judge there also allowed breach-of-contract and good-faith claims to proceed in February 2025, with class certification declarations due by September 2026.12LegalHIE. Judge Decides Class Action Lawsuit Can Proceed Against UnitedHealth for Use of AI A third case, Kisting-Leung v. Cigna, challenges a different tool called PxDx and is in discovery in the Eastern District of California.13Law360. The High-Stakes Healthcare AI Battles to Watch

A Senate Permanent Subcommittee on Investigations report published in October 2024, “Refusal of Recovery,” reviewed more than 280,000 internal documents from Humana, UnitedHealthcare, and CVS, which together cover about 60 percent of Medicare Advantage enrollees.14McKnight’s. Senate Report Hits Top 3 Medicare Advantage Insurers Over Refusal of Skilled Nursing, Other Coverage The report found that from 2019 to 2022, Humana’s denial rate for post-acute care was more than 16 times its denial rate for other medical services, reaching 24.6 percent of post-acute care requests in 2022.15LeadingAge. Analysis — Senate Report on MA Plans Reveals Troubling Data The subcommittee concluded that the three insurers appeared to be targeting post-acute care, substituting a calculation about financial gain for judgment about medical necessity. Humana disputed the findings and said the report “mischaracterizes the Medicare Advantage program and our clinical practices,” pointing to a 96 percent member satisfaction rating.16Skilled Nursing News. U.S. Senate Subcommittee Cites Serious Concerns on Medicare Advantage’s Denial of Post-Acute Care

On the regulatory side, a CMS final rule that took effect January 1, 2024, clarified that Medicare Advantage plans cannot use algorithms to make medical necessity decisions if those tools fail to account for a patient’s individual circumstances, including medical history, physician recommendations, and clinical notes.17CMS/CaHospital. HPMS Memo — FAQ on Coverage Criteria and Utilization Management Proposed rules that would have specifically addressed AI bias and discrimination in Medicare Advantage were not finalized under the current administration.18KFF. Regulation of AI in Prior Authorization and Claims Review